Meditech CEO leaves, chair steps down
Friday, 30 July, 2004
Meditech (ASX: MTR) is looking for a new CEO as CEO Chris Carter steps down, three months after a shareholder stoush forced his resignation from the company.
The problems arose at Meditech's AGM in late April, where Carter was due to stand for re-election to the board of directors. Slightly more than half of the proxy votes lodged, which represented about 12 per cent of all shareholders, voted against re-election, forcing Carter to withdraw his nomination and hand in his notice of resignation.
The stoush has also resulted in Bob Moses stepping down from his position as chairman of Meditech's board of directors, although he will remain a non-executive director for the time being. Richard Fox, former chairman of the company and a current director will take over as interim chairman.
According to a recent shareholder update from Moses, candidates for CEO are being interviewed at present, and a decision is likely to be announced shortly.
Giving rotavirus vaccine at birth benefits gut bacteria
Babies who receive a RV3-BB rotavirus vaccine at birth appear to show higher levels of good...
TGA approves donanemab for treatment of early Alzheimer's
The TGA has approved the first amyloid-targeting therapy for people with Alzheimer's in...
Ultra-processed foods linked to poor health, premature death
Evidence suggests a dose-response relationship between ultra-processed food consumption and...
